Comparatively, in the RA-FLS+M0+TNF-α+circ-CBLB group, inhibition of circ-CBLB combined with the addition of an M2 macrophage polarization inducer decreased the expression of TLR3, TRAF3, CD80, and CD86. The gene discussed is CD86; the disease is rheumatoid arthritis.